Pentavac Vaccine
Diphtheria + Tetanus + Pertussis + Hepatitis B + Hib Conjugate Vaccine
0.5 ML
Serum Institute Of India Ltd
| Pack size | |
|---|---|
| Dispensing mode | |
| Source | |
| Agent | |
| Retail Price | 943.99 NPR |
Indications
Pentavac Vaccine is used for:
For the prevention of serious childhood diseases: Diphtheria, Tetanus, Pertussis (whooping cough), Hepatitis B and Haemophilus Influenza type b.
Adult Dose
Child Dose
Intramuscular
Child
First dose is given at 6 weeks or 10 weeks or 14 weeks of age
Second dose is given anytime between 12-18 months of age
Renal Dose
Administration
Contra Indications
Hypersensitivity
Precautions
Hypersensitive) to glutaraldehyde, neomycin, streptomycin and polymyxin B. This is because these substances are used during the production of this vaccine and may be undetectable traces of these substances still in the vaccine.
Pregnancy-Lactation
Interactions
Adverse Effects
Side effects of Diphtheria + Tetanus + Pertussis + Hepatitis B + Hib Conjugate Vaccine :
Very common reactions (may affect more than 1 in 10 children)
•Loss of appetite
•Nervousness or irritability
•Abnormal crying
•Drowsiness
•Vomiting
•Redness at the injection ite
•Fever of 38°C or more
•Injection site swelling
•Injection site pain
Common r eactions (may affect up to 1 in 10 children)
•Diarrhoea
•Hardness (induration) at the site of the injection
•Disturbed sleep
Mechanism of Action
Note
Pentavac 0.5 ML Vaccine manufactured by Serum Institute Of India Ltd. Its generic name is Diphtheria + Tetanus + Pertussis + Hepatitis B + Hib Conjugate Vaccine. Pentavac is availble in Nepal.
Farmaco Nepal drug index information on Pentavac Vaccine is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.